Panelists provide an overview of the EUROPA trial and its key findings.
HR+ SABCS 2024 Highlights
Panelists provide an overview of the TAILORx trial and its key findings.
Panelists provide an overview of the PADMA trial and its key findings.
Panelists provide an overview of the EMBER-3 trial and its key findings.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
3
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
4
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
5
